Announcing Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System at ARVO Conference

LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it will release results

Announcing Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System at ARVO Conference Read More »